ES8802182A1 - Un procedimiento para preparar una linfotoxina. - Google Patents

Un procedimiento para preparar una linfotoxina.

Info

Publication number
ES8802182A1
ES8802182A1 ES543695A ES543695A ES8802182A1 ES 8802182 A1 ES8802182 A1 ES 8802182A1 ES 543695 A ES543695 A ES 543695A ES 543695 A ES543695 A ES 543695A ES 8802182 A1 ES8802182 A1 ES 8802182A1
Authority
ES
Spain
Prior art keywords
lymphotoxin
lymphoxin
nucleic acid
obtaining
acid encoding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES543695A
Other languages
English (en)
Other versions
ES543695A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/616,502 external-priority patent/US4959457A/en
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of ES8802182A1 publication Critical patent/ES8802182A1/es
Publication of ES543695A0 publication Critical patent/ES543695A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241—Tumor Necrosis Factors
    • C07K16/242—Lymphotoxin [LT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]
    • C07K14/5255—Lymphotoxin [LT]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241—Tumor Necrosis Factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

LA LINFOTOXINA, PRINCIPALMENTE LA BOVINA, SE PREPARA A) PROPORCIONANDO UN ACIDO NUCLEICO QUE CODIFICA LA LINFOTOXINA O PRELINFOTOXINA; B) PREPARANDO UN VECTOR REPLICABLE CON PROMOTOR PARA LA LINFOTOXINA; C) TRANSFORMANDO CON DICHO VECTOR UNA CELULA HOSPEDANTE, TIPO PROCARIOTICAS O ENCAROTICAS, COMO LAS LEVADURAS A LAS DE MAMIFERO NO HUMANAS; QUE SE CULTIVA Y D) EXTRAYENDO DE DICHO CULTIVO LA LINFOTOXINA. SE DESCRIBEN VARIANTES DE LA LINFOTOXINA, POR SUPRESION, SUSTITUCION O INSERCION DE UN GRUPO DE AMINOACIDOS EN POSICIONES ESPECIFICAS. SE PURIFICA EMPLEANDO UN NUEVO ANTICUERPO MONOCLONAL NEUTRALIZANTE DE LA LINFOTOXINA INMOVILIZADA. SE SUGIERE QUE LA LINFOTOXINA POSEE UNA ACTIVIDAD ANTITUMORAL POTENTE.
ES543695A 1984-05-31 1985-05-30 Un procedimiento para preparar una linfotoxina. Expired ES8802182A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US61650384A 1984-05-31 1984-05-31
US06/616,502 US4959457A (en) 1984-05-31 1984-05-31 Anti-lymphotoxin
US73231285A 1985-05-09 1985-05-09

Publications (2)

Publication Number Publication Date
ES8802182A1 true ES8802182A1 (es) 1988-04-16
ES543695A0 ES543695A0 (es) 1988-04-16

Family

ID=27417179

Family Applications (1)

Application Number Title Priority Date Filing Date
ES543695A Expired ES8802182A1 (es) 1984-05-31 1985-05-30 Un procedimiento para preparar una linfotoxina.

Country Status (23)

Country Link
EP (2) EP0164965B1 (es)
JP (3) JP2521703B2 (es)
AR (1) AR245219A1 (es)
AT (2) ATE195323T1 (es)
AU (1) AU599303B2 (es)
BG (1) BG60256B1 (es)
CA (1) CA1340641C (es)
CZ (1) CZ283148B6 (es)
DE (2) DE3587597T2 (es)
DK (1) DK171531B1 (es)
ES (1) ES8802182A1 (es)
FI (1) FI93025C (es)
GR (1) GR851317B (es)
HU (1) HU204085B (es)
IE (1) IE63487B1 (es)
IL (1) IL75318A (es)
NO (1) NO179075C (es)
NZ (1) NZ212207A (es)
PL (1) PL155410B1 (es)
PT (1) PT80573B (es)
RO (1) RO100383A2 (es)
SK (1) SK393085A3 (es)
YU (1) YU47735B (es)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK170476B1 (da) 1980-04-03 1995-09-11 Biogen Inc Rekombinant DNA-molekyle, uni-cellulær vært transformeret med mindst ét rekombinant DNA-molekyle, fremgangsmåde til transformering af en uni-cellulær vært, samt fremgangsmåder til fremstilling af et polpeptid, der udviser den immunologiske eller biologiske aktivitet af human beta-interferon
IL75318A (en) 1984-05-31 1994-08-26 Genentech Inc Recombinant human memotoxin and methods for its recombinant production
US5683688A (en) * 1984-05-31 1997-11-04 Genentech, Inc. Unglycosylated recombinant human lymphotoxin polypeptides and compositions
IL73883A (en) * 1984-12-20 1990-12-23 Yeda Res & Dev Monoclonal antibodies against tnf-alpha,hybridomas producing them and method for the purification of tnf-alpha
WO1986003751A2 (en) * 1984-12-21 1986-07-03 Biogen N.V. Purification, production and use of tumor necrosis factors
JPS62111928A (ja) * 1985-10-15 1987-05-22 Kanegafuchi Chem Ind Co Ltd 新規リンホトキシン
JPS62195285A (ja) * 1986-02-19 1987-08-28 Kanegafuchi Chem Ind Co Ltd リンホトキシン発現ベクタ−及びそれを用いるリンホトキシンの製造方法
AU603768B2 (en) * 1985-07-04 1990-11-29 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Lymphotoxin dna, lymphotoxin expression vector, lymphotoxin resistant cell, transformant with lymphotoxin expression vector and process for preparing lymphotoxin
US5403725A (en) * 1985-12-24 1995-04-04 Denki Kagaku Kogyo Kabushiki Kaisha Method for production of lymphotoxin (TNFB) in cell line A-C5-8
JP2548204B2 (ja) * 1987-06-27 1996-10-30 電気化学工業株式会社 新生理活性ポリペプチド
EP0230781B1 (en) * 1985-12-24 1992-07-22 Denki Kagaku Kogyo Kabushiki Kaisha Lymphotoxin gene, method for its production, and lymphotoxin
EP0230574A3 (en) * 1986-01-31 1989-03-22 Yale University Pharmaceutical compositions against infections caused by lav/htlv iii virus and the use thereof
JPS62181298A (ja) * 1986-02-05 1987-08-08 Kyowa Hakko Kogyo Co Ltd ヒトリンホトキシンポリペプチド誘導体
DE3620656A1 (de) * 1986-06-20 1987-12-23 Basf Ag Polypeptide mit lymphotoxin-aktivitaet oder lymphotoxin-aehnlicher aktivitaet, ihre herstellung und verwendung
JPS63105680A (ja) * 1986-10-22 1988-05-10 Kanegafuchi Chem Ind Co Ltd ヒト・リンホトキシン発現ベクタ−、該発現ベクタ−による形質転換細胞および該細胞を用いるリンホトキシンの製造方法
EP0272894A3 (en) * 1986-12-24 1989-06-14 Takeda Chemical Industries, Ltd. Recombinant human lymphotoxin
US5175268A (en) * 1986-12-24 1992-12-29 Takeda Chemical Industries, Ltd. DNA encoding recombinant human lymphotoxin
FI884798A7 (fi) * 1987-10-28 1989-04-29 Eisai Co Ltd Rekombinantlymfotoxin.
DE3837012A1 (de) * 1988-01-15 1989-07-27 Knoll Ag Verwendung von tnf und lt zur herstellung von arzneimitteln
GB2217326B (en) * 1988-04-08 1991-11-20 British Bio Technology Synthetic gene encoding human tumour necrosis factor beta.
EP0338497A3 (en) * 1988-04-22 1990-05-16 Takeda Chemical Industries, Ltd. Bispecific hybrid monoclonal antibody
JPH023698A (ja) * 1988-06-20 1990-01-09 Denki Kagaku Kogyo Kk ヒトリンホトキシンに対するモノクローナル抗体及びそれら抗体を産生するハイブリドーマ、並びにそれら抗体を用いたヒトリンホトキシンの精製方法、測定方法及び測定試薬
CA2001756A1 (en) * 1988-10-31 1991-04-30 Seiichi Uesugi New human lymphotoxin n-end deletion mutant
JPH03106821A (ja) * 1989-09-20 1991-05-07 Denki Kagaku Kogyo Kk 抗腫瘍剤
US5200176A (en) * 1989-10-06 1993-04-06 Genentech, Inc. Method for protection of ischemic tissues using tumor nerosis factor
US5370870A (en) * 1989-10-06 1994-12-06 Genentech, Inc. Method for protection against reactive oxygen species
IL97779A (en) * 1990-04-10 2000-01-31 Genentech Inc Compositions for cytoprotection against radiation and chemotherapy injury or risk thereof
US5747023A (en) * 1994-07-01 1998-05-05 Genentech, Inc. Cancer therapy using lymphotoxin
ES2179929T3 (es) * 1995-01-23 2003-02-01 Xenotech Inc Procedimiento que trata de inhibir la osteolisis y las metastasis.
US5925351A (en) 1995-07-21 1999-07-20 Biogen, Inc. Soluble lymphotoxin-β receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease
US6998116B1 (en) 1996-01-09 2006-02-14 Genentech, Inc. Apo-2 ligand
CA2318029C (en) 1998-01-15 2009-05-19 Genentech, Inc. Apo-2 ligand
EP1572116A4 (en) * 2002-11-26 2007-12-12 Genentech Inc COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE DISEASES
US7700097B2 (en) 2003-06-27 2010-04-20 Biogen Idec Ma Inc. Purification and preferential synthesis of binding molecules
US20050266004A1 (en) * 2003-12-08 2005-12-01 Jill Giles-Komar Anti-human lymphotoxin alpha antibodies, compositions, methods and uses
BRPI0509201A (pt) 2004-03-23 2007-08-28 Biogen Idec Inc agentes de acoplamento de receptor e usos terapêuticos destes
WO2006074399A2 (en) 2005-01-05 2006-07-13 Biogen Idec Ma Inc. Multispecific binding molecules comprising connecting peptides
NZ576032A (en) * 2006-10-12 2012-03-30 Genentech Inc Antibodies to lymphotoxin-alpha
US8338376B2 (en) 2006-10-20 2012-12-25 Biogen Idec Ma Inc. Compositions comprising variant LT-B-R-IG fusion proteins
NZ576424A (en) 2006-10-20 2012-09-28 Biogen Idec Inc Treatment of demyelinating disorders with soluble lymphotoxin-beta-receptor
AU2015249222A1 (en) * 2014-04-25 2016-11-17 Naurex, Inc. Stable compositions of neuroactive peptides

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU44186B (en) * 1978-12-22 1990-04-30 Biogen Nv Process for obtaining recombinant dnk molecules
NZ201918A (en) 1981-09-18 1987-04-30 Genentech Inc N-terminal methionyl analogues of bovine growth hormone
ZA834976B (en) * 1982-07-30 1984-08-29 Genentech Inc Human lymphotoxin
FI82266C (fi) * 1982-10-19 1991-02-11 Cetus Corp Foerfarande foer framstaellning av il-2 -mutein.
DE3331108A1 (de) * 1983-08-30 1985-05-02 Boehringer Ingelheim International GmbH, 6507 Ingelheim Verfahren zur herstellung von lymphotoxin und von lymphotoxin-mrna
EP0135797A3 (de) * 1983-08-30 1987-11-11 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Verfahren zur Herstellung von Lymphotoxin und von Lymphotoxin-mRNA
IL75318A (en) 1984-05-31 1994-08-26 Genentech Inc Recombinant human memotoxin and methods for its recombinant production

Also Published As

Publication number Publication date
JP2521703B2 (ja) 1996-08-07
PL155410B1 (en) 1991-11-29
AR245219A1 (es) 1993-12-30
IL75318A0 (en) 1985-09-29
JPH07250692A (ja) 1995-10-03
JP2804237B2 (ja) 1998-09-24
HUT37814A (en) 1986-02-28
DE3588225T2 (de) 2001-04-05
DE3588225D1 (de) 2000-09-14
EP0164965A3 (en) 1988-04-06
FI852143L (fi) 1985-12-01
IE851321L (en) 1985-11-30
EP0164965B1 (en) 1993-09-29
YU47735B (sh) 1996-01-08
FI93025C (fi) 1995-02-10
JPH07291995A (ja) 1995-11-07
EP0164965A2 (en) 1985-12-18
CA1340641C (en) 1999-07-13
NZ212207A (en) 1991-07-26
DK241385A (da) 1985-12-01
CZ393085A3 (en) 1997-07-16
AU599303B2 (en) 1990-07-19
NO179075B (no) 1996-04-22
SK278333B6 (en) 1996-11-06
DK171531B1 (da) 1996-12-23
ATE95243T1 (de) 1993-10-15
DK241385D0 (da) 1985-05-30
EP0509553B1 (en) 2000-08-09
FI93025B (fi) 1994-10-31
RO100383B1 (ro) 1991-03-01
FI852143A0 (fi) 1985-05-29
ATE195323T1 (de) 2000-08-15
CZ283148B6 (cs) 1998-01-14
GR851317B (es) 1985-11-25
PL253739A1 (en) 1986-03-11
YU91985A (en) 1988-12-31
JPS6156197A (ja) 1986-03-20
BG60256B2 (bg) 1994-03-24
DE3587597D1 (de) 1993-11-04
AU4320385A (en) 1985-12-05
BG60256B1 (bg) 1994-03-24
PT80573B (pt) 1987-08-19
DE3587597T2 (de) 1994-06-01
RO100383A2 (ro) 1991-10-17
IE930589L (en) 1985-11-30
EP0509553A1 (en) 1992-10-21
ES543695A0 (es) 1988-04-16
IL75318A (en) 1994-08-26
HU204085B (en) 1991-11-28
NO179075C (no) 1996-07-31
PT80573A (en) 1985-06-01
IE63487B1 (en) 1995-05-03
SK393085A3 (en) 1996-11-06
NO852173L (no) 1985-12-02

Similar Documents

Publication Publication Date Title
Cohen et al. Formation of pentose phosphate from 6-phosphogluconate
DK163187C (da) Fremgangsmaader til fremstilling af humant immuninterferon (gamma-interferon) samt dna-fragmenter, rekombinante klonings- og udtrykkelsesvektorer og rekombinante mikroorganismer og cellekulturer til anvendelse herved
Bauer et al. Immunologic relationship of purified human skin collagenase to other human and animal collagenases
Kerjan et al. The multienzyme complex containing nine aminoacyl-tRNA synthetases is ubiquitous from Drosophila to mammals
ES8500325A1 (es) Procedimiento para la preparacion de proteinas funcionales de uroquinasa humana.
DK0670896T3 (da) Kloning og ekspression af biologisk aktivt alfa-galactosidase A
CA2350226A1 (en) Protein expression vector and utilization thereof
ATE68014T1 (de) Die synthese eines proteins mittels eines identifizierungspeptids.
ES8702945A1 (es) Un metodo de producir activador de plasminogeno de tejido uterino humano
ATE85361T1 (de) Molekulare zuechtung.
DE69534227D1 (de) Stoffe und verfahren zur beherrschung der hyperakuten abstossung von menschlichen transplantaten
JPS57141287A (en) Rennin, preprorennin or prorennin gene obtained from recombined dna material and live cell containing gene
ATE68830T1 (de) Verfahren zur erhoehung der ausbeute von heterologen proteinen, produziert durch zuechtung von rekombinanten bakterien.
FI885679A0 (fi) Samuttryckning i eukariotiska celler.
ATE482714T1 (de) Modifizierter hitzeschockprotein-antigenpeptid- komplex
JPS6387983A (ja) 酵母の発現及び分泌クロ−ニングベクタ−
ES8500327A1 (es) Procedimiento para producir polipeptido
EP0111814A3 (en) The cloning and expression of nucleotide sequences encoding bovine growth hormone
JPS6420095A (en) Polypeptide having anti-blood coagulating action
JPS6485098A (en) Glycoprotein and production thereof
DE3852777D1 (de) Verfahren zur Konstruktion einer animalen Zellinie für die Herstellung von humanem Interferon-beta.
CN102010867A (zh) 重组中华蜜蜂王浆主蛋白AccMRJP1的酵母表达方法及产物用途
EP0307248A3 (en) Method for increasing the expression of polypeptides in recombinant cell culture
DE69027466D1 (de) Achromobacter-Protease-I-Gen sowie Genprodukt
ES2061524T3 (es) Un vector plasmidico para la expresion en bacillus y empleado para la clonacion del gen estructural que codifica la hormona de crecimiento humana y un metodo para la produccion de la hormona.

Legal Events

Date Code Title Description
FD2A Announcement of lapse in spain

Effective date: 20151230